Home > Press > Translume Launches Fused Silica Microfluidic Chips
Abstract:
Translume, Inc. announced today that it has launched a new line of fused silica microfluidic chips for bio, medical and chemical applications.
The company has already received several advance orders from major corporations and research institutions from around the world. Translume's customers will use these chips to advance the fields of genomics, proteomics, nanotechnology and particle counting.
"Our new line of microfluidic chips establishes Translume as a technical leader in the global market for lab-on-a-chip solutions," said Philippe Bado, President and Chief Technology Officer of Translume. "We have found that scientists and engineers across various fields share common needs for combining, analyzing, concentrating, purifying and interrogating fluids. We have a line of fused silica products that will meet these needs."
Translume's proprietary technology gives its chips several advantages over other commercial offerings, and at a competitive price. The company uses ultrafast femtosecond laser pulses to create deep three-dimensional microchannels with sharp-shaped features that are unavailable using traditional mask and etching techniques. In addition, Translume microfluidic chips are fabricated exclusively from high-quality fused silica glass, a chemically inert, UV-transparent, non auto-fluorescent material that is preferred for most bio-applications.
The new product line was made possible by an investment in 2007 from the State of Michigan's 21st Century Jobs Fund Program. Also, the company has previously received investments from two venture capital funds, Ardesta and Avalon Technology Ventures.
Translume plans to expand the new product line when it introduces micro-reactor, flow cytometer and capillary electrophoresis models later this year.
####
About Translume, Inc.
Translume, Inc. is headquartered in Ann Arbor, Michigan. The company was founded in 2001. The company's customers include players in the fields of defense, biomedicine and industrial monitoring.
For more information, please click here
Contacts:
Eric Jacobson
Translume, Inc.
655 Phoenix Drive
Ann Arbor, MI 48108
734-528-6371
Fax: 734-528-6334
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Flexible electronics integrated with paper-thin structure for use in space January 17th, 2025
Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025
Microfluidics/Nanofluidics
Implantable device shrinks pancreatic tumors: Taming pancreatic cancer with intratumoral immunotherapy April 14th, 2023
Researchers design new inks for 3D-printable wearable bioelectronics: Potential uses include printing electronic tattoos for medical tracking applications August 19th, 2022
Oregon State University research pushes closer to new therapy for pancreatic cancer May 6th, 2022
Chip Technology
Enhancing transverse thermoelectric conversion performance in magnetic materials with tilted structural design: A new approach to developing practical thermoelectric technologies December 13th, 2024
Bringing the power of tabletop precision lasers for quantum science to the chip scale December 13th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Quantum engineers ‘squeeze’ laser frequency combs to make more sensitive gas sensors January 17th, 2025
The National Space Society Congratulates SpaceX on Starship’s 7th Test Flight: Latest Test of the Megarocket Hoped to Demonstrate a Number of New Technologies and Systems January 17th, 2025
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |